RESUMO
Host plant volatiles have been shown to strongly synergize the attraction of some longhorn beetle species (Coleoptera: Cerambycidae) to their pheromones. This synergism is well documented among species that infest conifers, but less so for angiosperm-infesting species. To explore the extent of this phenomenon in the Cerambycidae, we first tested the responses of a cerambycid community to a generic pheromone blend in the presence or absence of chipped material from host plants as a source of host volatiles. In the second phase, blends of oak and conifer volatiles were reconstructed, and tested at low, medium, and high release rates with the pheromone blend. For conifer-infesting species in the subfamilies Spondylidinae and Lamiinae, conifer volatiles released at the high rate synergized attraction of some species to the pheromone blend. When comparing high-release rate conifer blend with high-release rate α-pinene as a single component, species responses varied, with Asemum nitidum LeConte being most attracted to pheromones plus α-pinene, whereas Neospondylis upiformis (Mannerheim) were most attracted to pheromones plus conifer blend and ethanol. For oak-infesting species in the subfamily Cerambycinae, with the exception of Phymatodes grandis Casey, which were most attracted to pheromones plus ethanol, neither synthetic oak blend nor ethanol increased attraction to pheromones. The results indicate that the responses to combinations of pheromones with host plant volatiles varied from synergistic to antagonistic, depending on beetle species. Release rates of host plant volatiles also were important, with some high release rates being antagonistic for oak-infesting species, but acting synergistically for conifer-infesting species.
Assuntos
Comportamento Animal , Besouros/fisiologia , Feromônios/metabolismo , Plantas/metabolismo , Volatilização , Animais , Bioensaio , Cromatografia GasosaRESUMO
PURPOSE: To determine whether perfusion computed tomography (CT)-derived vascular parameters-namely, blood flow, mean transit time (MTT), volume transfer constant (K(trans)), permeability-surface area product (PS), extracellular extravascular space volume, and vascular volume-correlate with the immunohistologic markers of angiogenesis in colorectal tumors. MATERIALS AND METHODS: This prospective study was approved by the Regional Ethics and Research and Development Committees. The perfusion CT protocol was incorporated in the staging CT after informed consent in 29 patients (14 men, 15 women; mean age, 70 years; age range, 55-94 years). The perfusion parameters were calculated over two regions of interest (ROIs), at the invasive and luminal site defined by two radiologists independently. Accurate representative data were captured manually by correcting for motion artifacts and were analyzed by using Matlab software. The vascular heterogeneity between ROIs was assessed by using the Wilcoxon signed rank test. Perfusion CT parameters were correlated with the microvessel density (MVD) count at both corresponding sites obtained by means of immunohistochemical staining of the selected histologic slide with factor VIII and CD105 antigens by using Spearmen rank coefficient. RESULTS: There was no statistically significant difference found between perfusion CT vascular parameters at the two ROIs by either of the radiologists. The Pearson coefficient for blood flow, MTT, K(trans), and PS at the two ROIs demonstrated good to moderate interobserver variability (for the two ROIs, 0.46 and 0.44; 0.67 and 0.64; 0.41 and 0.72; and 0.86 and 0.56, respectively). None of these parameters correlated with MVD count at the invasive or the luminal site for either of the two antigens. CONCLUSION: Perfusion CT measurements may measure vascularity of colorectal tumors, however, correlation with MVD, which is a morphologic measure, appears inappropriate. © RSNA, 2013.
Assuntos
Neoplasias Colorretais/irrigação sanguínea , Neoplasias Colorretais/diagnóstico por imagem , Neovascularização Patológica/diagnóstico por imagem , Tomografia Computadorizada por Raios X/métodos , Idoso , Idoso de 80 Anos ou mais , Artefatos , Meios de Contraste , Feminino , Humanos , Técnicas Imunoenzimáticas , Iohexol , Masculino , Microvasos , Pessoa de Meia-Idade , Estudos Prospectivos , Interpretação de Imagem Radiográfica Assistida por Computador , Estatísticas não ParamétricasRESUMO
The differences between Methia enigma Martins, 1981 and M. argentina Bruch, 1918 (Cerambycinae: Methiini) are discussed, and a new country record for the latter is provided. Sexual dimorphism in Pseudosparna Mermudes and Monné, 2009 (Lamiinae: Acanthocinini) is reported for the first time, and two new species of Pseudosparna (Lamiinae: Acanthocinini) are described from Panama: Pseudosparna dimitrisi sp. nov. and Pseudosparna marilenae sp. nov. The female of Pseudosparna mantis Devesa & Santos-Silva, 2020 is described for the first time. Eranina dariae sp. nov. (Lamiinae: Hemilophini) is described from French Guiana. The type locality of Bisaltes (Bisaltes) bimaculatus Aurivillius, 1904 (Lamiinae: Apomecynini) is reported, and a new country record is provided for the species. Aerenea subsulcicollis Breuning, 1948 (= A. sulcicollis subsulcicollis) (Lamiinae: Compsosomatini) is synonymized with A. sulcicollis Melzer, 1932, and a new country record is provided. A new state record is provided for Schmidarius kondratieffi Santos-Silva, Heffern, Botero & Nascimento, 2020 (Lamiinae: Hemilophini). Tucumaniella Breuning, 1943 (Apomecynini) is synonymized with Cacostola Fairmaire & Germain, 1859 (Onciderini), and Tucumaniella brevipes Breuning, 1943 is synonymized with Cacostola volvula (Fabricius, 1787).
Assuntos
Besouros , Mantódeos , Aranhas , Feminino , AnimaisRESUMO
We report the identification, synthesis, and field bioassays of a female-produced sex attractant pheromone for the cerambycid beetle Desmocerus californicus californicus Horn. Headspace volatiles from females contained a sex-specific compound, (R)-desmolactone [(4R,9Z)-hexadec-9-en-4-olide], which elicited strong responses from the antennae of adult males in coupled gas chromatography-electroantennogram analyses. Short syntheses of both enantiomers were developed from commercial chiral synthons. In field bioassays, significant numbers of males were collected in traps baited with (R)-desmolactone, whereas the (S)-enantiomer attracted no males. The racemate was less attractive than the pure (R)-enantiomer, indicating some degree of antagonism by the unnatural enantiomer. This compound is the first example of a new structural class of cerambycid pheromones, and is the second pheromone identified for a species in the subfamily Lepturinae.
Assuntos
Besouros/metabolismo , Lactonas/metabolismo , Atrativos Sexuais/metabolismo , Animais , Bioensaio , Besouros/efeitos dos fármacos , Feminino , Lactonas/síntese química , Lactonas/química , Lactonas/farmacologia , Masculino , Atrativos Sexuais/síntese química , Atrativos Sexuais/química , Atrativos Sexuais/farmacologiaRESUMO
Recent work suggests that closely related cerambycid species often share pheromone components, or even produce pheromone blends of identical composition. However, little is known of the pheromones of species in the subfamily Prioninae. During field bioassays in California, males of three species in the prionine genus Tragosoma were attracted to 2,3-hexanediols, common components of male-produced aggregation pheromones of beetles in the subfamily Cerambycinae. We report here that the female-produced sex pheromone of Tragosoma depsarium "sp. nov. Laplante" is (2R,3R)-2,3-hexanediol, and provide evidence from field bioassays and electroantennography that the female-produced pheromone of both Tragosoma pilosicorne Casey and T. depsarium "harrisi" LeConte may be (2S,3R)-2,3-hexanediol. Sexual dimorphism in the sculpting of the prothorax suggests that the pheromone glands are located in the prothorax of females. This is the second sex attractant pheromone structure identified from the subfamily Prioninae, and our results provide further evidence of pheromonal parsimony within the Cerambycidae, in this case extending across both subfamily and gender lines.
Assuntos
Besouros/efeitos dos fármacos , Besouros/metabolismo , Glicóis/metabolismo , Glicóis/farmacologia , Atrativos Sexuais/biossíntese , Atrativos Sexuais/farmacologia , Animais , Bioensaio , Besouros/química , Feminino , Cromatografia Gasosa-Espectrometria de Massas , Glicóis/análise , Glicóis/química , Isomerismo , Masculino , Odorantes/análise , Atrativos Sexuais/análise , Atrativos Sexuais/químicaRESUMO
Two new species of longhorned beetles (Coleoptera: Cerambycidae) from Central America are described and illustrated: Crossomeles copei sp. nov. and Crossomeles oscarcastilloi sp. nov. (Cerambycinae: Rhinotragini) from Mexico and Costa Rica, respectively. A key to the known species of Crossomeles Chemsak Noguera, 1993 is provided. Also, two new country records are reported: Crossomeles acutipennis Chemsak Noguera, 1993 from Panama; and Oncideres fisheri Dillon Dillon, 1946 (Lamiinae: Onciderini) from the United States of America.
Assuntos
Besouros , Animais , América Central , Estados UnidosRESUMO
OBJECTIVE: To assess local recurrence, disease-free survival, and overall survival in magnetic resonance imaging (MRI)-predicted good prognosis tumors treated by surgery alone. BACKGROUND: The MERCURY study reported that high-resolution MRI can accurately stage rectal cancer. The routine policy in most centers involved in the MERCURY study was primary surgery alone in MRI-predicted stage II or less and in MRI "good prognosis" stage III with selective avoidance of neoadjuvant therapy. PATIENTS AND METHODS: Data were collected prospectively on all patients included in the MERCURY study who were staged as MRI-defined "good" prognosis tumors. "Good" prognosis included MRI-predicted safe circumferential resection margins, with MRI-predicted T2/T3a/T3b (less than 5 mm spread from muscularis propria), regardless of MRI N stage. None received preoperative or postoperative radiotherapy. Overall survival, disease-free survival, and local recurrence were calculated. RESULTS: Of 374 patients followed up in the MERCURY study, 122 (33%) were defined as "good prognosis" stage III or less on MRI. Overall and disease-free survival for all patients with MRI "good prognosis" stage I, II and III disease at 5 years was 68% and 85%, respectively. The local recurrence rate for this series of patients predicted to have a good prognosis tumor on MRI was 3%. CONCLUSIONS: The preoperative identification of good prognosis tumors using MRI will allow stratification of patients and better targeting of preoperative therapy. This study confirms the ability of MRI to select patients who are likely to have a good outcome with primary surgery alone.
Assuntos
Imageamento por Ressonância Magnética/métodos , Recidiva Local de Neoplasia/diagnóstico , Neoplasias Retais/diagnóstico , Neoplasias Retais/cirurgia , Reto/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Análise de Variância , Biópsia por Agulha , Colectomia/métodos , Intervalos de Confiança , Intervalo Livre de Doença , Europa (Continente) , Feminino , Seguimentos , Humanos , Imuno-Histoquímica , Estimativa de Kaplan-Meier , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Invasividade Neoplásica/patologia , Recidiva Local de Neoplasia/mortalidade , Estadiamento de Neoplasias , Variações Dependentes do Observador , Cuidados Pré-Operatórios/métodos , Modelos de Riscos Proporcionais , Estudos Prospectivos , Neoplasias Retais/mortalidade , Análise de Sobrevida , Fatores de Tempo , Resultado do TratamentoRESUMO
BACKGROUND: In rectal cancer, the standard of care after the completion of radiotherapy is surgery at 6 to 8 weeks. However, there is variation regarding the timing of surgery. OBJECTIVE: This investigation aimed to audit the timing of surgery following radiotherapy and to compare perioperative morbidity and tumor downstaging in patients operated on, before and after the 6- to 8-week window. DESIGN: A retrospective review of rectal cancers treated preoperatively in our cancer network over a 27-month period. The effect of "time till surgery" of 6 to 8 weeks, <6 weeks, and >8 weeks on T downstaging and nodal downstaging was calculated by univariate and multivariate logistic regression analyses. SETTING: This study was conducted in an oncology tertiary referral center in the Southwest London Cancer Network. PATIENTS: Patients receiving preoperative radiotherapy for primary locally advanced rectal cancer undergoing subsequent surgical resection were eligible. MAIN OUTCOME MEASURES: The primary outcome measurement was time to surgery following the completion of (chemo) radiotherapy. Thirty-day perioperative morbidity and mortality and tumor and nodal downstaging were examined according to the timing of surgery. LIMITATIONS: This study was limited by its nonrandomized retrospective design and the lack of standardization of preoperative chemotherapy. RESULTS: Thirty-two (34%) patients underwent surgery at 6 to 8 weeks, 45 (47%) at >8 weeks, and 18 (19%) at <6 weeks after radiotherapy. Delay was attributed to scheduling in 87% of cases and to comorbidities in the remainder. T downstaging occurred in 6 (33.3%) patients in the <6 weeks group, in 12 (37.5%) in the 6 to 8 weeks group, and in 28 (62.2%) in >8 weeks group with no significant differences in perioperative morbidity. On multivariate analysis, T downstaging was significantly greater for the >8 weeks group (OR, 3.79; 95% CI: 1.11-12.99; P = .03). More patients were staged ypT0-T2, 19 of 45 (42%) in the >8 weeks group vs other groups, 14 of 50 (28%, P < .05). CONCLUSIONS: Following radiotherapy, surgery frequently occurs at >8 weeks and is associated with increased downstaging. The consequences on survival and perioperative morbidity warrant further investigation.
Assuntos
Neoplasias Retais/patologia , Neoplasias Retais/terapia , Adulto , Idoso , Idoso de 80 Anos ou mais , Quimioterapia Adjuvante , Feminino , Humanos , Metástase Linfática , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Estadiamento de Neoplasias , Radioterapia Adjuvante , Estudos Retrospectivos , Fatores de Tempo , Resultado do TratamentoRESUMO
OBJECTIVE: A literature review of agents used to induce chemical sphincterotomy after hemorrhoidectomy. METHODS: Electronic databases were searched from January 1935 to August 2010. RESULTS: Two randomized controlled trials compared calcium channel blockers (Ca2) with placebo. Pain appeared to be less for up to 7 days, and its side-effect profile was comparable to the control group. Four randomized controlled trials examined the role of glyceryl trinitrate (GTN). GTN may be used up to 6 weeks to aid healing. Pain may be slightly less during its use and potentially offers less pain during defecation in the first 48 h. Its side-effect profile including headache appears comparable to placebo. Three randomized controlled trials investigated botulinum toxin A (BTX). BTX may be used to aid healing after hemorrhoidectomy. Pain may be less for up to a week after surgery. Its side-effect profile including incontinence to flatus appears comparable to placebo. It would be especially useful in cases where poor patient compliance is envisaged. Only one paper was found comparing BTX with GTN. BTX may be preferred over GTN due to better pain control and fewer side effects. CONCLUSION: BTX, Ca2, and GTN may give effective pain relief for a week after hemorrhoidectomy. Their side-effect profiles are comparable to placebo.
Assuntos
Canal Anal/cirurgia , Procedimentos Cirúrgicos do Sistema Digestório/métodos , Hemorroidas/cirurgia , Canal Anal/efeitos dos fármacos , Analgesia , Toxinas Botulínicas/farmacologia , Toxinas Botulínicas/uso terapêutico , Bloqueadores dos Canais de Cálcio/farmacologia , Bloqueadores dos Canais de Cálcio/uso terapêutico , Procedimentos Cirúrgicos do Sistema Digestório/efeitos adversos , Diretrizes para o Planejamento em Saúde , Hemorroidas/tratamento farmacológico , Humanos , Nitroglicerina/farmacologia , Nitroglicerina/uso terapêutico , Medição da Dor , Complicações Pós-Operatórias/etiologia , Ensaios Clínicos Controlados Aleatórios como Assunto , Cicatrização/efeitos dos fármacosRESUMO
OBJECTIVES: Our objective was to establish the primary mode of imaging and MR protocols utilised in the preoperative staging of deeply infiltrating endometriosis in centres accredited by the British Society of Gynaecological Endoscopy (BSGE). METHODS: The lead consultant radiologist in each centre was invited to complete an online survey detailing their protocols. RESULTS: Out of 49 centres, 32 (65%) responded to the survey. Two centres performed transvaginal ultrasound as the primary method for preoperative staging of deeply infiltrating endometriosis and the remainder performed MRI. 21/25 centres did not recommend a period of fasting prior to MRI and 22/25 administered hyoscine butylbromide. None of the centres routinely offered bowel preparation or recommended a specific pre-procedure diet. 21/25 centres did not time imaging according to the woman's menstrual cycle, and instructions regarding bladder filling were varied. Rectal and vaginal opacification methods were infrequently utilised. All centres preferentially performed MRI in the supine position - six used an abdominal strap and four could facilitate prone imaging. Just under half of centres used pelvic-phased array coils and three centres used gadolinium contrast agents routinely. All centres performed T1W with fat-suppression and T2W without fat-suppression sequences. There was significant variation relating to other MR sequences depending on the unit. CONCLUSIONS: There was significant inconsistency between centres in terms of MR protocols, patient preparation and the sequences performed. Many practices were out of line with current published evidence. ADVANCES IN KNOWLEDGE: Our survey demonstrates a need for evidence-based standardisation of imaging in BSGE accredited endometriosis centres.
Assuntos
Endometriose/diagnóstico por imagem , Imageamento por Ressonância Magnética/métodos , Protocolos Clínicos , Meios de Contraste , Endometriose/patologia , Feminino , HumanosRESUMO
We report the identification, synthesis, and field bioassays of a volatile, male-produced aggregation pheromone of a long-horned beetle, the banded alder borer, Rosalia funebris Mots. Headspace collections from males contained a major male-specific compound, (Z)-3-decenyl (E)-2-hexenoate, and several minor components, identified as (Z)-3-decenol, (Z)-3-nonenyl (E)-2-hexenoate, and (Z)-3-decenyl (E)-3-hexenoate. The antennae of both males and females responded strongly to (Z)-3-decenyl (E)-2-hexenoate. We collected significant numbers of adult R. funebris in field bioassays using traps baited with this compound. This pheromone structure is unprecedented in the literature of cerambycid pheromones and distinct from the more common diol/hydroxyketone pheromone motif of many other species of the diverse subfamily Cerambycinae. This is the first pheromone identified for a species in the tribe Rosaliini.
Assuntos
Besouros/fisiologia , Atrativos Sexuais/isolamento & purificação , Atrativos Sexuais/farmacologia , Animais , Caproatos/síntese química , Caproatos/isolamento & purificação , Caproatos/farmacologia , Cromatografia Gasosa , Feminino , Masculino , Atrativos Sexuais/síntese química , Comportamento Sexual Animal/efeitos dos fármacos , VolatilizaçãoRESUMO
The multidisciplinary team (MDT) is considered good practice in the management of chronic conditions and is now a well-established part of clinical care in the NHS. There has been a recent drive to have MDTs in the management of women with severe endometriosis requiring complex surgery as a result of recommendations from the European Society for Human Reproduction and Embryology (ESHRE) and British Society for Gynaecological Endoscopy (BSGE). The multidisciplinary approach to the management of patients with endometriosis leads to better results in patient outcomes; however, there are potentially a number of barriers to its implementation and maintenance. This paper aims to review the potential benefits, disadvantages and barriers of the multidisciplinary team in the management of severe endometriosis.
RESUMO
PURPOSE: Neoadjuvant therapy is traditionally reserved for locally advanced mid and low rectal cancers. In tumors above this level, the need for adjuvant treatment is based on poor histopathologic features, but this approach has potential disadvantages. The aim of this study was to determine whether magnetic resonance imaging (MRI) could accurately stage tumors of the distal sigmoid, rectosigmoid, and upper rectum and help direct preoperative treatment. MATERIALS AND METHODS: A total of 75 patients with distal sigmoid, rectosigmoid, and upper rectal tumors were assessed preoperatively by MRI. If tumor extended beyond the planned surgical resection plane, chemoradiotherapy was offered. RESULTS: Of the 75 patients, 57 (76%) underwent primary surgery. Agreement between the MRI prognosis and histopathologic findings was 84% (95% confidence interval [CI], 72.6-92.7%). The other 18 patients underwent neoadjuvant chemoradiotherapy for poor prognostic features with predicted surgical resection margin involvement. The histopathologic examination confirmed tumor downstaging in 9 of the 18 patients who underwent chemoradiotherapy. The 3-year survival rate in the good prognosis group (91%; 95% CI, 77.1-97.3%) was not significantly different from that of the chemoradiotherapy group (81.4%; 95% CI, 52.4-93.6%). The poor prognosis group undergoing primary surgery had significantly worse survival (62.2%; 95% CI, 30.3-82.8%, p < 0.03). CONCLUSION: Our findings indicate that tumors of the distal sigmoid, rectosigmoid, and upper rectum can be staged accurately using high spatial resolution MRI and that those with poor prognostic disease may benefit from preoperative therapy.
Assuntos
Imageamento por Ressonância Magnética , Estadiamento de Neoplasias/métodos , Neoplasias Retais , Neoplasias do Colo Sigmoide , Adulto , Idoso , Idoso de 80 Anos ou mais , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Terapia Combinada/métodos , Feminino , Fluoruracila/administração & dosagem , Humanos , Masculino , Pessoa de Meia-Idade , Mitomicina/administração & dosagem , Prognóstico , Dosagem Radioterapêutica , Neoplasias Retais/tratamento farmacológico , Neoplasias Retais/patologia , Neoplasias Retais/radioterapia , Neoplasias Retais/cirurgia , Estudos Retrospectivos , Neoplasias do Colo Sigmoide/tratamento farmacológico , Neoplasias do Colo Sigmoide/patologia , Neoplasias do Colo Sigmoide/radioterapia , Neoplasias do Colo Sigmoide/cirurgia , Taxa de SobrevidaRESUMO
A revision of the American species of Prionus Geoffroy, 1762 is presented. Prionus (Neopolyarthron) Semenov, 1899 and Prionus (Antennalia) Casey, 1912 are synonymized with Prionus Geoffroy, 1762. Homaesthesis LeConte, 1873 is considered a true subgenus of Prionus. Prionus (Homaesthesis) rhodocerus Linsley, 1957 and Prionus (Homaesthesis) linsleyi Hovore, 1981 are synonymized with Prionus simplex (Casey, 1912). Prionus beauvoisi Lameere, 1915 and Prionus (Neopolyarthron) debilis Casey, 1924 are synonymized with P. imbricornis (Linnaeus, 1767). Prionus (Neopolyarthron) townsendi Casey, 1912 and Prionus (Neopolyarthron) curticollis Casey, 1912 are synonymized with Prionus mexicanus Bates, 1884. Prionus batesi Lameere, 1920 is synonymized with Prionus aztecus Casey, 1912. Prionus hintoni Linsley, 1935 is synonymized with Prionus flohri Bates, 1884. Prionus (Antennalia) fissicornis parviceps Casey, 1912 is excluded as the synonym of Prionus fissicornis Haldeman, 1846 and instead synonymized with P. imbricornis (Linnaeus, 1767). Prionus (Prionus) validiceps Casey, 1912 is excluded from the synonymy of P. pocularis Dalman, 1817, and synonymized with P. (P.) californicus Motschulsky, 1845. Prionus (Prionus) tumidus Casey, 1912 is excluded from the synonymy of P. heroicus Semenov, 1907, and synonymized with P. (P.) californicus. The lectotype female and the paralectotype male of Prionus (Prionus) tristis are excluded from the synonym of P. (P.) heroicus and transferred to the synonym of P. (P.) californicus; the paralectotype female of P. (P.) tristis is maintained in the synonymy of P. (P.) heroicus. Prionus (Prionus) fontinalis Casey, 1914 is excluded from the synonymy of P. (P.) heroicus and synonymized with P. (P.) californicus. Prionus simplex is formally excluded from the Cerambycidae fauna of Oklahoma, USA. Comments on the page, plate, and figure of publication of Cerambyx laticollis Drury, 1773 are presented. Prionus (Trichoprionus) Fragoso & Monné, 1982 is considered a genus different from Prionus. Hypoprionus is designated as a replacement name for Prionellus Casey, 1924 and Cerambyx laticollis Drury, 1773 is designated as the type species. Comments on the type localities of Prionus emarginatus, Prionus palparis Say, 1824, and Prionus (Neopolyarthron) aztecus Casey, 1912 are presented. Prionus (Homaesthesis) integer sensu Linsley (1962) and Chemsak (1996) is described as P. (H.) geminus, new species. Comments on the date of publication of Prionus fissicornis Haldeman, 1846 are presented. Comments on the status of the syntypes of Cerambyx imbricornis Linnaeus, 1767 are also presented. Lectotype specimens for Prionus flohri Bates, 1884, Prionus (Prionus) tristis, and Prionus lecontei Lameere, 1912 are designated. Comments on the number of specimens used in the original description of Prionus californicus are presented, and a lectotype for this species is designated. New state records are presented for Prionus emarginatus Say, 1824; P. imbricornis (Linnaeus, 1767); P. aztecus Casey, 1912; P. poultoni Lameere, 1912; P. pocularis Dalman, 1817; and P. mexicanus Bates, 1884.
Assuntos
Besouros/anatomia & histologia , Besouros/classificação , Animais , Feminino , Masculino , América do Norte , Especificidade da EspécieRESUMO
AIM: To systematically review the survival outcomes relating to extramural venous invasion in rectal cancer. METHODS: A systematic review was conducted using PRISMA guidelines. An electronic search was carried out using MEDLINE, EMBASE, CINAHL, Cochrane library databases, Google scholar and PubMed until October 2014. Search terms were used in combination to yield articles on extramural venous invasion in rectal cancer. Outcome measures included prevalence and 5-year survival rates. These were graphically displayed using Forest plots. Statistical analysis of the data was carried out. RESULTS: Fourteen studies reported the prevalence of extramural venous invasion (EMVI) positive patients. Prevalence ranged from 9%-61%. The pooled prevalence of EMVI positivity was 26% [Random effects: Event rate 0.26 (0.18, 0.36)]. Most studies showed that EMVI related to worse oncological outcomes. The pooled overall survival was 39.5% [Random effects: Event rate 0.395 (0.29, 0.51)]. CONCLUSION: Historically, there has been huge variation in the prevalence of EMVI through inconsistent reporting. However the presence of EMVI clearly leads to worse survival outcomes. As detection rates become more consistent, EMVI may be considered as part of risk-stratification in rectal cancer. Standardised histopathological definitions and the use of magnetic resonance imaging to identify EMVI will improve detection rates in the future.
Assuntos
Neoplasias Retais/patologia , Veias/patologia , Humanos , Invasividade Neoplásica , Valor Preditivo dos Testes , Prognóstico , Neoplasias Retais/mortalidade , Neoplasias Retais/terapia , Fatores de Risco , Análise de SobrevidaRESUMO
OBJECTIVE:: The aim of this study was to assess the accuracy of 1.5-T MRI in the pre-operative local T and N staging of colon cancer and identification of extramural vascular invasion (EMVI). METHODS:: Between 2010 and 2012, 60 patients with adenocarcinoma of the colon were prospectively recruited at 2 centres. 55 patients were included for final analysis. Patients received pre-operative 1.5-T MRI with high-resolution T2 weighted, gadolinium-enhanced T1 weighted and diffusion-weighted images. These were blindly assessed by two expert radiologists. Accuracy of the T-stage, N-stage and EMVI assessment was evaluated using post-operative histology as the gold standard. RESULTS:: Results are reported for two readers. Identification of T3 disease demonstrated an accuracy of 71% and 51%, sensitivity of 74% and 42% and specificity of 74% and 83%. Identification of N1 disease demonstrated an accuracy of 57% for both readers, sensitivity of 26% and 35% and specificity of 81% and 74%. Identification of EMVI demonstrated an accuracy of 74% and 69%, sensitivity 63% and 26% and specificity 80% and 91%. CONCLUSION:: 1.5-T MRI achieved a moderate accuracy in the local evaluation of colon cancer, but cannot be recommended to replace CT on the basis of this study. ADVANCES IN KNOWLEDGE:: This study confirms that MRI is a viable alternative to CT for the local assessment of colon cancer, but this study does not reproduce the very high accuracy reported in the only other study to assess the accuracy of MRI in colon cancer staging.
RESUMO
PURPOSE: The prognostic relevance of preoperative high-resolution magnetic resonance imaging (MRI) assessment of circumferential resection margin (CRM) involvement is unknown. This follow-up study of 374 patients with rectal cancer reports the relationship between preoperative MRI assessment of CRM staging, American Joint Committee on Cancer (AJCC) TNM stage, and clinical variables with overall survival (OS), disease-free survival (DFS), and time to local recurrence (LR). PATIENTS AND METHODS: Patients underwent protocol high-resolution pelvic MRI. Tumor distance to the mesorectal fascia of ≤ 1 mm was recorded as an MRI-involved CRM. A Cox proportional hazards model was used in multivariate analysis to determine the relationship of MRI assessment of CRM to survivorship after adjusting for preoperative covariates. RESULTS: Surviving patients were followed for a median of 62 months. The 5-year OS was 62.2% in patients with MRI-clear CRM compared with 42.2% in patients with MRI-involved CRM with a hazard ratio (HR) of 1.97 (95% CI, 1.27 to 3.04; P < .01). The 5-year DFS was 67.2% (95% CI, 61.4% to 73%) for MRI-clear CRM compared with 47.3% (95% CI, 33.7% to 60.9%) for MRI-involved CRM with an HR of 1.65 (95% CI, 1.01 to 2.69; P < .05). Local recurrence HR for MRI-involved CRM was 3.50 (95% CI, 1.53 to 8.00; P < .05). MRI-involved CRM was the only preoperative staging parameter that remained significant for OS, DFS, and LR on multivariate analysis. CONCLUSION: High-resolution MRI preoperative assessment of CRM status is superior to AJCC TNM-based criteria for assessing risk of LR, DFS, and OS. Furthermore, MRI CRM involvement is significantly associated with distant metastatic disease; therefore, colorectal cancer teams could intensify treatment and follow-up accordingly to improve survival outcomes.
Assuntos
Imageamento por Ressonância Magnética , Recidiva Local de Neoplasia/diagnóstico , Neoplasias Retais/diagnóstico , Neoplasias Retais/cirurgia , Adulto , Idoso , Idoso de 80 Anos ou mais , Análise de Variância , Fatores de Confusão Epidemiológicos , Progressão da Doença , Intervalo Livre de Doença , Europa (Continente) , Feminino , Seguimentos , Humanos , Estimativa de Kaplan-Meier , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Razão de Chances , Valor Preditivo dos Testes , Período Pré-Operatório , Prognóstico , Modelos de Riscos Proporcionais , Neoplasias Retais/mortalidade , Neoplasias Retais/patologia , Projetos de PesquisaRESUMO
We report here that (4R,9Z)-hexadec-9-en-4-olide [(R)-desmolactone] is a sex attractant or sex pheromone for multiple species and subspecies in the cerambycid genus Desmocerus. This compound was previously identified as a female-produced sex attractant pheromone of Desmocerus californicus californicus. Headspace volatiles from female Desmocerus aureipennis aureipennis contained (R)-desmolactone, and the antennae of adult males of two species responded strongly to synthetic (R)-desmolactone in coupled gas chromatography-electroantennogram analyses. In field bioassays in California, Oregon, and British Columbia, traps baited with synthetic (R)-desmolactone captured males of several Desmocerus species and subspecies. Only male beetles were captured, indicating that this compound acts as a sex-specific attractant, rather than as a signal for aggregation. In targeted field bioassays, males of the US federally threatened subspecies Desmocerus californicus dimorphus responded to the synthetic attractant in a dose dependent manner. Our results represent the first example of a "generic" sex pheromone used by multiple species in the subfamily Lepturinae, and demonstrate that pheromone-baited traps may be a sensitive and efficient method of monitoring the threatened species Desmocerus californicus dimorphus, commonly known as the valley elderberry longhorn beetle.
Assuntos
Besouros/metabolismo , Lactonas/análise , Atrativos Sexuais/química , Animais , Feminino , MasculinoRESUMO
PURPOSE: To assess magnetic resonance imaging (MRI) and pathologic staging after neoadjuvant therapy for rectal cancer in a prospectively enrolled, multicenter study. METHODS: In a prospective cohort study, 111 patients who had rectal cancer treated by neoadjuvant therapy were assessed for response by MRI and pathology staging by T, N and circumferential resection margin (CRM) status. Tumor regression grade (TRG) was also assessed by MRI. Overall survival (OS) was estimated by using the Kaplan-Meier product-limit method, and Cox proportional hazards models were used to determine associations between staging of good and poor responders on MRI or pathology and survival outcomes after controlling for patient characteristics. RESULTS: On multivariate analysis, the MRI-assessed TRG (mrTRG) hazard ratios (HRs) were independently significant for survival (HR, 4.40; 95% CI, 1.65 to 11.7) and disease-free survival (DFS; HR, 3.28; 95% CI, 1.22 to 8.80). Five-year survival for poor mrTRG was 27% versus 72% (P = .001), and DFS for poor mrTRG was 31% versus 64% (P = .007). Preoperative MRI-predicted CRM independently predicted local recurrence (LR; HR, 4.25; 95% CI, 1.45 to 12.51). Five-year survival for poor post-treatment pathologic T stage (ypT) was 39% versus 76% (P = .001); DFS for the same was 38% versus 84% (P = .001); and LR for the same was 27% versus 6% (P = .018). The 5-year survival for involved pCRM was 30% versus 59% (P = .001); DFS, 28 versus 62% (P = .02); and LR, 56% versus 10% (P = .001). Pathology node status did not predict outcomes. CONCLUSION: MRI assessment of TRG and CRM are imaging markers that predict survival outcomes for good and poor responders and provide an opportunity for the multidisciplinary team to offer additional treatment options before planning definitive surgery. Postoperative histopathology assessment of ypT and CRM but not post-treatment N status were important postsurgical predictors of outcome.